Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer.

Authors

Maxine Sun
Firas Abdollah, Henry Ford HealthFollow

Recommended Citation

Sun M, and Abdollah F. Re: Ar-v7 and resistance to enzalutamide and abiraterone in prostate cancer. Eur Urol 2015; 68(1):162-163.

Document Type

Article

Publication Date

7-1-2015

Publication Title

European urology

Medical Subject Headings

Androstenols; Drug Resistance, Neoplasm; Humans; Male; Phenylthiohydantoin; Prostatic Neoplasms; RNA, Neoplasm; Receptors, Androgen

PubMed ID

26088731

Volume

68

Issue

1

First Page

162

Last Page

163